Lv5
990 积分 2024-05-15 加入
[¹⁷⁷Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer
4天前
已完结
Prostate Cancer Radioligand Therapy: PSMA and Beyond, Current Landscape and Future Directions
5天前
已完结
68Ga-FAPI-LM3, a novel FAP and SSTR2 dual targeting peptide heterodimer for PET imaging of nasopharyngeal carcinoma
5天前
已关闭
Preclinical evaluation of a dual sstr2 and integrin αvβ3-targeted heterodimer [68Ga]-NOTA-3PEG4-TATE-RGD
5天前
已关闭
Synthesis and Preclinical Evaluation of Dual-Specific Probe Targeting Glypican-3 and Prostate-Specific Membrane Antigen for Hepatocellular Carcinoma PET Imaging
5天前
已完结
A Novel PSMA/FAP-Specific Radiotracer 99mTc-HFaPSMA for Diagnosis of PSMA-Negative Prostate Cancer: From Preclinical Validation to Clinical Translation
5天前
已完结
Antibody-Drug Conjugates in Prostate Cancer: A Systematic Review
5天前
已关闭
The non-small-cell lung cancer drug market
7天前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
1个月前
已完结
HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence
1个月前
已完结
皖公网安备34019202002308
